Official Journal of Research Center for Gastroenterology and Liver Diseases

e-ISSN 1735-3408

p-ISSN 1735-143X

Citation data

CrossRef

Works that cite this article, indexed by Crossref.

20 resultsUpdated October 25, 2026

← Back to article

Liver Fibrosis is Associated with NAFLD Activity Score in Chronic Hepatitis B Patients with Liver Steatosis

Hepatitis Monthly In Press(In Press) (2018)

Li-Li Wu; Jing Zhou; Qing-Xian Cai; Ya-Xin Huang; Dong-Ying Xie; Zhi-Liang Gao; Hong Deng

Optimal thresholds for ultrasound attenuation parameter in the evaluation of hepatic steatosis severity: evidence from a cohort of patients with biopsy-proven fatty liver disease

European Journal of Gastroenterology & Hepatology 33(3) (2021)

Sheng-Hao Zhu; Kenneth I. Zheng; Di-Shuang Hu; Feng Gao; Rafael S. Rios; Gang Li; Yang-Yang Li; Christopher D. Byrne; Giovanni Targher; Yong-Ping Chen; Ming-Hua Zheng

Effect of 5:2 intermittent fasting diet versus daily calorie restriction eating on metabolic-associated fatty liver disease—a randomized controlled trial

Frontiers in Nutrition 11 (2024)

Yuan-yuan Wang; Fang Tian; Xiao-lu Qian; Hui-min Ying; Zhen-feng Zhou

MicroRNA‐30b regulates insulin sensitivity by targeting SERCA2b in non‐alcoholic fatty liver disease

Liver International 39(8) (2019)

Li‐Li Dai; Shu‐De Li; Yi‐Cheng Ma; Jun‐Rui Tang; Jun‐Yan Lv; Yuan‐Qing Zhang; Ying‐Lei Miao; Yan‐Qiong Ma; Chun‐Mei Li; Yi‐You Chu; Kun‐Hua Wang; Lan‐Qing Ma; Cheng‐Gang Zou

Identification of BR102910 as a selective fibroblast activation protein (FAP) inhibitor

Bioorganic & Medicinal Chemistry Letters 37 (2021)

Hui Jin Jung; Eun Hye Nam; Jin Young Park; Prithwish Ghosh; In Su Kim

Fecal Microbiota Transplantation for the Treatment of Nonalcoholic Fatty Liver Disease

Exploratory Research and Hypothesis in Medicine 4(1) (2019)

Lan-Feng Xue; Wen-Hui Luo; Li-Hao Wu; Xing-Xiang He; Harry Hua-Xiang Xia; Yu Chen

Diagnostic value of FibroTouch in identifying hepatic steatosis in NAFLD with MRI‐PDFF as the reference standard

Journal of Digestive Diseases 24(12) (2023)

Rong Mu; You Chen Xia; Kou Yun Zhu; Jing Yi Lu; Qian Luo; Lei Zhang; Ren Kun Lin; Xiao Bo Cai; Ying Qu; Lun Gen Lu

Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease

PLOS ONE 16(5) (2021)

Ying Zhuang Ng; Lee Lee Lai; Sui Weng Wong; Siti Yatimah Mohamad; Kee Huat Chuah; Wah Kheong Chan; Daisuke Tokuhara

Comparison of gut microbiota in male MAFLD patients with varying liver stiffness

Frontiers in Cellular and Infection Microbiology 12 (2022)

Yuheng Zhang; Su Yan; Shifeng Sheng; Qian Qin; Jingfeng Chen; Weikang Li; Tiantian Li; Xinxin Gao; Lin Wang; Li Ang; Suying Ding

The defining of the reference range of liver stiffness and fat attenuation parameter for healthy Chinese children

European Journal of Gastroenterology & Hepatology 33(11) (2021)

Fansen Zeng; Haiyan Wang; Xufang Li

Prediction of posthepatectomy liver failure using transient elastography in patients with hepatitis B related hepatocellular carcinoma

BMC Gastroenterology 17(1) (2017)

Jie-wen Lei; Xiao-yu Ji; Jun-feng Hong; Wan-bin Li; Yan Chen; Yan Pan; Jia Guo

Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B

Medicine 98(49) (2019)

Wei Yue; Yan Li; Jiawei Geng; Ping Wang; Li Zhang

A statistical analysis of the correlations among various types of clinical indexes for patients with chronic hepatitis B

Medicine 99(8) (2020)

Jie Wang; Yonglan Pu; Yinhua Gong; Zhonghua Li; Xiaofang Zhu

Liver fibrosis is independently associated with diabetic peripheral neuropathy in type 2 diabetes mellitus

Journal of Diabetes Investigation 12(11) (2021)

Jinya Huang; Rumei Li; Naijia Liu; Na Yi; Hangping Zheng; Qi Zhang; Lianying Zhou; Linuo Zhou; Renming Hu; Bin Lu

Mechanical microenvironment as a key cellular regulator in the liver

Acta Mechanica Sinica 35(2) (2019)

Zhifeng You; Lyu Zhou; Wenjing Li; Chenyu Huang; Yanan Du

Interferon-α could induce liver steatosis to promote HBsAg loss by increasing triglyceride level

Heliyon 10(12) (2024)

Lili Wu; Zhihui Li; Na Gao; Hong Deng; Qiyi Zhao; Zhaoxia Hu; Junfeng Chen; Ziying Lei; Jinhua Zhao; Bingliang Lin; Zhiliang Gao

Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience

Annals of Hepatology 30(1) (2025)

Thanikan Sukaram; Soe Thiha Maung; Yuda Chongpison; Tassanan Jaihan; Chonlada Phathong; Roongruedee Chaiteerakij